Symphony on same hymn sheet with agreement for anti-microbial product

By Joe Whitworth

- Last updated on GMT

E.coli is one of the bacteria targeted
E.coli is one of the bacteria targeted
Symphony Environmental Technologies has signed a five year supply and marketing agreement with a division of Johnson & Johnson for anti-fungal and anti-bacterial technology for plastic applications.

Janssen PMP (a division of Janssen Pharmaceutica) and Symphony have been working together to introduce a masterbatch for plastic products at the manufacturing stage.

The aim is to control bacteria such as E.coli, Salmonella, Listeria, Pseudomonas, and Aspergillus Niger; and algae and fungi such as M. Piriformis and P. Roqueforti.  

It will be sold by Symphony and co-branded under the d2p brand name with commercial sales volumes for food-contact applications expected to come in 2014/15.

Michael Laurier, chief executive of Symphony, said: "We are already negotiating with large global users after positive laboratory tests and manufacturing trials with them, and await regulatory approval which we anticipate will be granted during 2014.” 

Related topics Food safety & quality

Related news

Follow us

Products

View more

Webinars